Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

US Patent 7449570 · Granted Nov 11, 2008

Estimated economic value: $276,564,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds for treating spinal muscular atrophy2023
Substituted reverse pyrimidine Bmi-1 inhibitors2021
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid f2021
Processes for the preparation of substituted tetrahydro beta-carbolines2021
Compounds for treating spinal muscular atrophy2020
Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid2020
Substituted pyridine and pyrazine BMI-1 inhibitors2020
Methods for treating epilepsy2019
Compounds for treating spinal muscular atrophy2019
Substituted reverse pyrimidine Bmi-1 inhibitors2019
Substituted pyrimidine Bmi-1 inhibitors2019
Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid f2019